| Drugs | Mechanism of action |
| Virus-based approaches | |
| Remdesvir | Terminates premature viral chain |
| Galidesvir | Terminates premature viral chain |
| Favipiravir | Inhibits RdRp |
| Ribavirin | Inhibits viral RNA synthesis |
| Penciclovir | Inhibits RdRp |
| Nafamostat | Inhibits entry |
| Griffithsin | Inhibits entry |
| Lopinavir | Decreases viral load |
| Ritonavir | Increases the bio-availability of ritonavir |
| Darunavir | Prevents viral replication |
| camostat mesylate | Blocks TMPRSS2 |
| ASC09F | Decreases viral load |
| Host-based approaches | |
| Recombinant interferons | Exogenous interferons |
| Chloroquine | Blocks viral entry |
| Nitazoxanide | Induces host innate immune response |
| Tocilizumab | Suppresses host immunity |
| Interferon-I | Modulates immune response |
| Glucocorticoids | Inhibit cytokine production |